Type(s) of Cancer
Prostate
Prostate
Study Phase
Phase 3
Study Completion Date
2011-05
2011-05
NCT00617669Uploaded 07-16-2020
Available for Download
PDS UID: Prostat_Multipl_2008_420
A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 10 mg ZD4054 (Zibotentan) in Combination With Docetaxel in Comparison With Docetaxel in Patients With Metastatic Hormone-resistant Prostate Cancer
Files:![](/projectdatasphere/Images/icons/icon-docx.png)
![](/projectdatasphere/Images/icons/icon-xlsx.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-xlsx.png)
![](/projectdatasphere/Images/icons/icon-sas7bdat.png)
![](/projectdatasphere/Images/icons/icon-docx.png)
PROTOCOLLinked Prostate_AstraZe_2008_104 Documentation.docx
![](/projectdatasphere/Images/icons/icon-xlsx.png)
CRFDataset Contents and Variable Crosswalk.xlsx
![](/projectdatasphere/Images/icons/icon-pdf.png)
DATA DICTIONARYCODEBOOK_linked_prostate104.pdf
![](/projectdatasphere/Images/icons/icon-pdf.png)
DATA SUMMARYProc Contents Data Dictionary Linked_Prostate104.pdf
![](/projectdatasphere/Images/icons/icon-xlsx.png)
DATA SUMMARYDescriptive_Stats_Linked_Prostat_AstraZe_2008_104.xlsx
![](/projectdatasphere/Images/icons/icon-sas7bdat.png)
DATA (COMPARATOR ARM)linked_prostate104.sas7bdat